Advertisement

Advertisement

GNPX Stock Latest News

Genprex Secures Canadian Patent for Reqorsa Lung Cancer Therapy

Company AnnouncementsGenprex Secures Canadian Patent for Reqorsa Lung Cancer Therapy

Genprex says CIPO issues Notice of Allowance for patent

PremiumThe Fly

Genprex says CIPO issues Notice of Allowance for patent

12d ago

Genprex Shareholders Approve Expanded Equity Plan, Reverse Split

PremiumCompany Announcements

Genprex Shareholders Approve Expanded Equity Plan, Reverse Split

16d ago

Genprex Faces Nasdaq Delisting Notice, Plans Compliance Steps

PremiumCompany Announcements

Genprex Faces Nasdaq Delisting Notice, Plans Compliance Steps

21d ago

Genprex files $250M mixed securities shelf

PremiumThe Fly

Genprex files $250M mixed securities shelf

29d ago

Genprex Highlights Biomarker Data for Reqorsa Lung Cancer Therapy

PremiumCompany AnnouncementsGenprex Highlights Biomarker Data for Reqorsa Lung Cancer Therapy

1M ago

Genprex collaborators present positive preclinical data of GPX-002 in diabetes

The Fly

Genprex collaborators present positive preclinical data of GPX-002 in diabetes

2M ago

Genprex Announces Positive Preclinical Data for Diabetes Gene Therapy

Company Announcements

Genprex Announces Positive Preclinical Data for Diabetes Gene Therapy

2M ago

Genprex receives patent grant from The Israel Patent Office

PremiumThe Fly

Genprex receives patent grant from The Israel Patent Office

2M ago

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel

PremiumCompany Announcements

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel

2M ago

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy

PremiumCompany Announcements

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy

2M ago

Genprex Expands Lung Cancer Gene Therapy Research Collaboration

PremiumCompany Announcements

Genprex Expands Lung Cancer Gene Therapy Research Collaboration

2M ago

Genprex enters research agreement with UT MD Anderson

PremiumThe FlyGenprex enters research agreement with UT MD Anderson

2M ago

Genprex announces presentations on Reqorsa Gene Therapy at 2026 AACR

The Fly

Genprex announces presentations on Reqorsa Gene Therapy at 2026 AACR

2M ago

Genprex Highlights New Reqorsa Preclinical Data at AACR

Company Announcements

Genprex Highlights New Reqorsa Preclinical Data at AACR

4M ago

Genprex collaborators present on use of Reqorsa at AACR meeting

PremiumThe Fly

Genprex collaborators present on use of Reqorsa at AACR meeting

4M ago

Genprex Secures Key Global Patents for REQORSA Therapy

PremiumCompany Announcements

Genprex Secures Key Global Patents for REQORSA Therapy

4M ago

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

PremiumThe Fly

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

4M ago

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

PremiumCompany Announcements

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

5M ago

Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

PremiumThe FlyGenprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

5M ago

Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

Company Announcements

Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

6M ago

Genprex advances GPX-002 diabetes gene therapy program

Company Announcements

Genprex advances GPX-002 diabetes gene therapy program

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >